A detailed history of Sofinnova Investments, Inc. transactions in Immatics N.V. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 796,704 shares of IMTX stock, worth $9.35 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
796,704
Previous 2,163,646 63.18%
Holding current value
$9.35 Million
Previous $22.7 Million 59.29%
% of portfolio
0.51%
Previous 1.32%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$9.78 - $13.49 $13.4 Million - $18.4 Million
-1,366,942 Reduced 63.18%
796,704 $9.26 Million
Q1 2024

Aug 14, 2024

BUY
$10.23 - $12.94 $14 Million - $17.7 Million
1,366,942 Added 171.57%
2,163,646 $22.7 Million
Q1 2024

May 15, 2024

SELL
$10.23 - $12.94 $8.24 Million - $10.4 Million
-805,393 Reduced 27.13%
2,163,646 $22.7 Million
Q4 2023

Aug 15, 2024

BUY
$7.36 - $10.89 $16 Million - $23.7 Million
2,172,335 Added 272.67%
2,969,039 $31.3 Million
Q4 2023

Feb 12, 2024

SELL
$7.36 - $10.89 $533,217 - $788,958
-72,448 Reduced 2.38%
2,969,039 $31.3 Million
Q2 2023

Aug 14, 2023

SELL
$5.92 - $12.72 $539,945 - $1.16 Million
-91,207 Reduced 2.91%
3,041,487 $35.1 Million
Q1 2023

May 11, 2023

BUY
$6.74 - $9.44 $7.63 Million - $10.7 Million
1,131,918 Added 56.57%
3,132,694 $21.6 Million
Q4 2022

Feb 13, 2023

BUY
$8.05 - $11.58 $11.8 Million - $17 Million
1,468,260 Added 275.72%
2,000,776 $17.4 Million
Q3 2022

Nov 08, 2022

SELL
$3.31 - $13.06 $2.52 Million - $9.95 Million
-761,587 Reduced 58.85%
532,516 $5.33 Million
Q2 2022

Aug 15, 2022

BUY
$6.0 - $9.37 $156,240 - $243,994
26,040 Added 2.05%
1,294,103 $11.3 Million
Q1 2022

May 16, 2022

BUY
$6.64 - $12.85 $1.6 Million - $3.1 Million
241,440 Added 23.52%
1,268,063 $10.1 Million
Q4 2021

Feb 14, 2022

BUY
$10.81 - $14.38 $5.93 Million - $7.89 Million
548,407 Added 114.68%
1,026,623 $13.8 Million
Q3 2021

Nov 15, 2021

BUY
$11.58 - $15.46 $403,516 - $538,719
34,846 Added 7.86%
478,216 $6.22 Million
Q2 2021

Aug 16, 2021

BUY
$10.43 - $12.81 $607,766 - $746,451
58,271 Added 15.13%
443,370 $5.15 Million
Q1 2021

May 14, 2021

BUY
$10.24 - $14.6 $1.08 Million - $1.54 Million
105,567 Added 37.77%
385,099 $4.32 Million
Q4 2020

Feb 16, 2021

SELL
$9.67 - $12.05 $444,771 - $554,239
-45,995 Reduced 14.13%
279,532 $3.02 Million
Q3 2020

Nov 13, 2020

BUY
$8.73 - $15.15 $2.84 Million - $4.93 Million
325,527 New
325,527 $3.45 Million

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $894M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.